Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)

CUSIP: 03969K108

Q1 2022 13F Holders as of 31 Mar 2022

Security identity
Shares outstanding
123,454,843
Holder snapshot
Share change
-6,428,138
Put/Call ratio
13%
Reported price per share
$19.26
Number of holders
106
Value change
-$136,426,148
Number of buys
50
Number of sells
35

Security key

03969K108

Report period

Q1 2022

Institutions

106

Top holders

10

Ownership snapshot

Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FRAZIER MANAGEMENT LLC
13D/G signal
Evidence rows
15
Latest as of
31 Dec 2021
13F Lead comparable stake: 6.8% Showing 1-6 of 15 holder rows.

Rank 2 holder

FMR LLC

13F
Ownership
6.1%
Position
$156.47M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
FRAZIER MANAGEMENT LLC
13F
Company
13F
6.8%
$174,926,000
8,434,232 shares
31 Dec 2021
FMR LLC
13F
Company
13F
6.1%
$156,467,000
7,544,212 shares
31 Dec 2021
ORBIMED ADVISORS LLC
13F
Company
13F
4.9%
$125,972,000
6,073,850 shares
31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
3.5%
$89,471,000
4,313,864 shares
31 Dec 2021
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
3.2%
$82,531,000
3,979,292 shares
31 Dec 2021
Point72 Asset Management, L.P.
13F
Company
13F
2.1%
$54,840,000
2,644,177 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
106
Shares
48,307,139
Rows available
106
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
89
Q1 2022 holders
106
Holder diff
17
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .